This site is intended for healthcare professionals
Drug news

U.S. Court of Appeals ruled in favor of Eli Lilly, confirming that the Alimta vitamin regimen patent would be infringed by competitors with an alternative salt form of pemetrexed prior to the patent expiry.

Read time: 1 mins
Last updated:12th Aug 2019
Published:12th Aug 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest